Skip to content

Science News About Bipolar Disorder

Rapid Agent Restores Pleasure-seeking Ahead of Other Antidepressant Action

Press Release

Dorsal anterior cingulate cortex

A drug being studied as a fast-acting mood-lifter restored pleasure-seeking behavior independent of – and ahead of – its other antidepressant effects.

Continue Reading…

Suspect Gene Corrupts Neural Connections

Press Release

Synapses in mature iPSC cortex neuron Hongjun Song iPSC

Researchers have shown in patients’ cells how a rare mutation in a suspect gene disrupts the expression of dozens of other genes underlying neural connections.

Continue Reading…

Brain Region Singled Out for Social Memory, Possible Therapeutic Target for Select Brain Disorders

Science Update

highlighted CA2 region of hippocampus in mouse brain

The hippocampus houses learning and memory—specifically the storage of knowledge of who, what, where, and when. Using a special transgenic mouse, researchers have now pinpointed a hippocampal region called CA2 that is important for social memory, the ability of animal to recognize another of the same species. Understanding this region could be useful in understanding and treating disorders characterized by altered social behaviors such as schizophrenia, bipolar disorder, and autism.

Continue Reading…

New Data Reveal Extent of Genetic Overlap Between Major Mental Disorders

Press Release

SNP-based Coheritibilities

The largest genome-wide study of its kind has determined how much five major mental illnesses are traceable to the same common inherited genetic variations.

Continue Reading…

Ketamine Cousin Rapidly Lifts Depression Without Side Effects

Science Update

GLX-13 Thumbnail

NMDA or glutamate receptor modulators as antidepressants have come of age. Human clinical studies demonstrated that ketamine can ward off depressive symptoms within 2 hours of administration and last for several days. Yet serious side effects are attached to this drug, including excessive sleepiness, hallucinations, and substance abuse behavior.

Continue Reading…

Flu in Pregnancy May Quadruple Child’s Risk for Bipolar Disorder

Press Release

H1N1 influenza virus particles

Pregnant mothers’ exposure to the flu has been linked to a nearly 4-fold increased risk for bipolar disorder in their adult child.

Continue Reading…

NIH Study Shows People with Serious Mental Illnesses Can Lose Weight

Press Release

project achieve thumbnail

Losing weight is challenging for everyone. It can be particularly difficult for someone with a serious mental illness. An NIMH-funded clinical study proves that a modified diet and exercise program can work for people with serious mental illnesses. Participants lost 7 pounds more than controls—and continued to lose weight.

Continue Reading…

Five Major Mental Disorders Share Genetic Roots

Science Update

Dr. Bruce Cuthbert, Ph.D.

Five major mental disorders share some of the same genetic risk factors, the largest genome-wide study of its kind has found.

Continue Reading…

Rate of Bipolar Symptoms Among Teens Approaches That of Adults

Science Update

teen girl talking to therapist

National survey data finds that the rate of bipolar symptoms in teens is similar to that found in adults, indicating that bipolar disorder often begins in adolescence.

Continue Reading…

Pattern Recognition Technology May Help Predict Future Mental Illness in Teens

Science Update

MRI machine

Computer programs that automatically spot patterns in data may help predict a person’s risk for future mental disorders.

Continue Reading…

Gene Regulator in Brain’s Executive Hub Tracked Across Lifespan – NIH study

Press Release

PFC methylation

For the first time, scientists have tracked the activity, across the lifespan, of an environmentally responsive regulatory mechanism that turns genes on and off in the brain’s executive hub. Among key findings of the study by National Institutes of Health scientists: genes implicated in schizophrenia and autism turn out to be members of a select club of genes in which regulatory activity peaks during an environmentally-sensitive critical period in development.

Continue Reading…

Atypical Antipsychotic More Effective than Older Drugs in Treating Childhood Mania, but Side Effects Can Be Serious

Science Update

young children feeling frustrated

The antipsychotic medication risperidone is more effective for initial treatment of mania in children diagnosed with bipolar disorder compared to other mood stabilizing medications, but it carries the potential for serious metabolic side effects, according to an NIMH-funded study published online ahead of print January 2, 2012, in the Archives of General Psychiatry.

Continue Reading…

International Impact of Bipolar Disorder Highlights Need for Recognition and Better Treatment Availability

Science Update

Person sitting next to railroad tracks.

The severity and impact of bipolar disorder and bipolar-like symptoms are similar across international boundaries, according to a study partially funded by NIMH.

Continue Reading…

Most Children with Rapidly Shifting Moods Don’t Have Bipolar Disorder

Science Update

child running in an open field

Relatively few children with rapidly shifting moods and high energy have bipolar disorder, though such symptoms are commonly associated with the disorder. Instead, most of these children have other types of mental disorders, according to an NIMH-funded study published online ahead of print in the Journal of Clinical Psychiatry on October 5, 2010.

Continue Reading…

Rapid Antidepressant Works by Boosting Brain’s Connections

Science Update

neuronal spines on ketamine-treated rat neurons

An experimental drug that lifts depression in hours likely works by rapidly stimulating connections between brain cells, a study in rats has revealed. The drug, called ketamine, quickly generated such synapses in a brain circuit implicated in human depression by triggering a key enzyme.

Continue Reading…

Symptoms of Bipolar Disorder May Go Undiagnosed in Some Adults with Major Depression

Science Update

Woman contemplating

Nearly 40 percent of people with major depression may also have subthreshold hypomania, a form of mania that does not fully meet current diagnostic criteria for bipolar disorder, according to a new NIMH-funded study. The study was published online ahead of print August 15, 2010, in the American Journal of Psychiatry.

Continue Reading…

Experimental Medication Lifts Depression Symptoms in Bipolar Disorder Within an Hour

Science Update

lighted brain with blue glow

People with treatment-resistant bipolar disorder experienced relief from symptoms of depression in as little as 40 minutes after an intravenous dose of the anesthetic medication ketamine in a preliminary study; while the patient group was small, this work adds to evidence that compounds in the class to which ketamine belongs have potential as rapid and effective medications for depression, including bipolar depression.

Continue Reading…

Imaging Studies Help Pinpoint Child Bipolar Circuitry

Science Update

Amygdala activation

A series of imaging studies are revealing that the brain works differently in youth with bipolar disorder (BD) than in chronically irritable children who are often diagnosed with pediatric BD.

Continue Reading…

Genes and Circuitry, Not Just Clinical Observation, to Guide Classification for Research

Science Update

3D MRI model of brain

NIMH is launching a long-term project aimed at ultimately improving treatment and prevention by studying classification of mental illness, based on genetics and neuroscience in addition to clinical observation. The Research Domain Criteria (RDoC) project is not intended to replace psychiatry’s existing diagnostic system for practitioners and will proceed in an independent direction, said Bruce Cuthbert, Ph.D., Director of the NIMH Division of Adult Translational Research, who is directing the effort. By taking a fresh look – without preconceived categories – the project aims to improve the validity of classification for researchers.

Continue Reading…

Same Genes Suspected in Both Depression and Bipolar Illness

Science Update

protein made by PBRM1 gene

Researchers, for the first time, have pinpointed a genetic hotspot that confers risk for both bipolar disorder and depression. People with either of these mood disorders were significantly more likely to have risk versions of genes at this site than healthy controls. One of the genes, which codes for part of a cell’s machinery that tells genes when to turn on and off, was also found to be over-expressed in the executive hub of bipolar patients’ brains, making it a prime suspect. The results add to mounting evidence that major mental disorders overlap at the molecular level.

Continue Reading…

Schizophrenia and Bipolar Disorder Share Genetic Roots

Press Release

gene chip

A trio of genome-wide studies – collectively the largest to date – has pinpointed a vast array of genetic variation that cumulatively may account for at least one third of the genetic risk for schizophrenia. One of the studies traced schizophrenia and bipolar disorder, in part, to the same chromosomal neighborhoods.

Continue Reading…

Symptoms Persist as Bipolar Children Grow Up

Science Update

Bipolar disorder (BD) identified in childhood often persisted into adulthood in the first large follow-up study of its kind.

Continue Reading…

New Study to Evaluate Ways to Control Metabolic Side Effects of Antipsychotics

Press Release

A new NIMH-funded grant will examine ways to control the metabolic side effects associated with the use of the newer atypical antipsychotic medications in children with schizophrenia or bipolar disorder.

Continue Reading…

Family-Focused Therapy Effective in Treating Depressive Episodes of Bipolar Youth

Science Update

Adolescents with bipolar disorder who received a nine-month course of family-focused therapy (FFT) recovered more quickly from depressive episodes and stayed free of depression for longer periods than a control group, according to an NIMH-funded study published September 2008 in the Archives of General Psychiatry.

Continue Reading…

Largest Study of Its Kind Implicates Gene Abnormalities in Bipolar Disorder

Press Release

The largest genetic analysis of its kind to date for bipolar disorder has implicated machinery involved in the balance of sodium and calcium in brain cells.

Continue Reading…

Mice Expressing Human Genes Bred to Help Unravel Mental Disorders

Science Update

New mouse strains engineered to express human genes related to mental disorders are being developed under a recently-launched grant program from NIMH’s Division of Neuroscience and Basic Behavioral Science.

Continue Reading…

Potential New Target Found for Developing Medications to Treat Bipolar Disorder

Science Update

Medications that target the protein BAG1, which regulates a process that can trigger symptoms in people who have bipolar disorder, may offer a new way of treating the disease, according to NIMH scientists.

Continue Reading…

New NIMH Research to Test Innovative Treatments for Children with ADHD

Science Update

Two new grants funded by NIMH will focus on novel and innovative approaches to treating children who have attention deficit hyperactivity disorder (ADHD).

Continue Reading…

Imaging Identifies Brain Regions and Chemicals Underlying Mood Disorders; May Lead to Better Treatments

Science Update

WASHINGTON, DC, May 6 — Recently developed imaging techniques allow the mapping of the brain circuits and chemical systems believed responsible for a range of mood abnormalities including depression and bipolar disorder, and hold promise for improved treatments, scientists say.

Continue Reading…

Bipolar Youths’ Misreading of Faces May be Risk Marker for Illness

Science Update

Youngsters with pediatric bipolar disorder and healthy peers who have first-degree relatives with bipolar disorder share the same difficulty labeling facial emotions, NIMH researchers have discovered. Reporting in the February 2008 online edition of the American Journal of Psychiatry, the scientists suggest that the facial emotion recognition impairment might be part of an inherited predisposition to the illness.

Continue Reading…

Tomorrow’s Antidepressants: Skip the Serotonin Boost?

Science Update

New research adds to evidence of potentially better molecular targets in the brain to treat depression and other mental disorders, according to NIMH-funded scientists.

Continue Reading…

Faster-Acting Medications for Bipolar Disorder’s Manic Phase May Be Feasible

Science Update

Scientists may be able to develop faster-acting medications for the manic phase of bipolar disorder, new research shows.

Continue Reading…

Mood Disorders Predict Later Substance Abuse Problems

Science Update

People with manic symptoms and bipolar disorder type II are at significant risk of later developing an alcohol abuse or dependence problem, a long-term study conducted in Switzerland confirms. The study was published in the January 2008 issue of the Archives of General Psychiatry.

Continue Reading…

Bipolar Disorder Phenome Database May Aid Search for Related Genes

Science Update

Early findings from the recently launched Bipolar Disorder Phenome Database were published in the August 2007 issue of the American Journal of Psychiatry.

Continue Reading…

Manic Phase of Bipolar Disorder Benefits from Breast Cancer Medication

Press Release

The medication tamoxifen, best known as a treatment for breast cancer, dramatically reduces symptoms of the manic phase of bipolar disorder more quickly than many standard medications for the mental illness, a new study shows.

Continue Reading…

Rates of Bipolar Diagnosis in Youth Rapidly Climbing, Treatment Patterns Similar to Adults

Press Release

The number of visits to a doctors office that resulted in a diagnosis of bipolar disorder in children and adolescents has increased by 40 times over the last decade, reported researchers funded in part by the NIH.

Continue Reading…

Studies Refine Understanding of Treatments for Bipolar Disorder

Science Update

Two new studies provide additional details on best practices for treating people with bipolar disorder, a sometimes debilitating illness marked by severe mood swings between depression and mania.

Continue Reading…

Bipolar Youth Show Distinct Pattern of Brain Development

Science Update

The first picturess of the brain changing before-and-after the onset of pediatric bipolar disorder reveal a distinct pattern of development, when compared to that seen in healthy youth or in childhood onset schizophrenia.

Continue Reading…

Parents' Diagnoses Help to Distinguish Childhood Bipolar Disorder from Severe Mood Dysregulation

Science Update

The parents of children who have bipolar disorder are more likely to have bipolar disorder themselves than the parents of children who have severe mood dysregulation (SMD).

Continue Reading…

NIMH Funds Research for Early Intervention in Childhood Bipolar Disorder

Science Update

NIMH recently approved funding to test the effectiveness of an early intervention in children at high risk for developing bipolar disorder.

Continue Reading…

Genetic Roots of Bipolar Disorder Revealed by First Genome-Wide Study of Illness

Press Release

The likelihood of developing bipolar disorder depends in part on the combined, small effects of variations in many different genes in the brain, none of which is powerful enough to cause the disease by itself, a new study shows.

Continue Reading…

Bipolar Spectrum Disorder May Be Underrecognized and Improperly Treated

Press Release

A new study supports earlier estimates of the prevalence of bipolar disorder in the U.S. population, and suggests the illness may be more accurately characterized as a spectrum disorder.

Continue Reading…

Gene Knockout Unleashes Manic Mouse

Science Update

Mice engineered to lack a specific gene showed behaviors similar to human mania in a study funded in part by NIMH; they were hyperactive, slept less, appeared less depressed and anxious, and craved sugar, cocaine and pleasure stimulation.

Continue Reading…

Intensive Psychotherapy More Effective Than Brief Therapy for Treating Bipolar Depression

Press Release

Patients taking medications to treat bipolar disorder are more likely to get well faster and stay well if they receive intensive psychotherapy, according to results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), funded by the National Institutes of Health’s (NIH) National Institute of Mental Health (NIMH).

Continue Reading…

Study Sheds Light on Medication Treatment Options for Bipolar Disorder

Press Release

For depressed people with bipolar disorder who are taking a mood stabilizer, adding an antidepressant medication is no more effective than a placebo (sugar pill), according to results published online on March 28, 2007 in the New England Journal of Medicine.

Continue Reading…

Extreme Irritability: Is It Childhood Bipolar Disorder?

Press Release

Results of a new study may help improve the diagnosis and treatment of two debilitating childhood mental disorders — pediatric bipolar disorder (BD) and a syndrome called severe mood dysregulation (SMD).

Continue Reading…

Different Families, Different Characteristics — Different Kinds of Bipolar Disorder?

Science Update

People with bipolar disorder (BPD) tend to share similarities in certain characteristics with other members of their families, NIMH-funded researchers have shown.

Continue Reading…

Landmark Council Session Spotlights “Real World” Trials

Science Update

Principal investigators of NIMHs four large-scale clinical trials presented study results and their implications at the National Advisory Mental Health Council meeting on September 15, 2006.

Continue Reading…

New Research Helps to Improve Understanding of Bipolar Disorder in Youth

Science Update

Bipolar disorder may be hard to identify in children and adolescents for several reasons, including a lack of age-appropriate diagnostic guidelines and symptoms different than those commonly seen in adults with the disorder.

Continue Reading…

NIMH Researchers Discover Medication’s Antidepressant Potential

Science Update

A commonly used sedative and motion-sickness treatment shows promise as a fast-acting antidepressant, according to a study conducted by researchers at NIMH.

Continue Reading…

Bipolar Disorder Exacts Twice Depression’s Toll in Workplace, Productivity Lags Even After Mood Lifts

Press Release

Bipolar disorder costs twice as much in lost productivity as major depressive disorder, an NIMH funded study has found.

Continue Reading…

Obesity Linked with Mood and Anxiety Disorders

Science Update

Results of an NIMH-funded study show that nearly one out of four cases of obesity is associated with a mood or anxiety disorder, but the causal relationship and complex interplay between the two is still unclear.

Continue Reading…

Intermittent Explosive Disorder Affects up to 16 Million Americans

Press Release

A little-known mental disorder marked by episodes of unwarranted anger is more common than previously thought, a study funded by NIMH has found.

Continue Reading…

Fear Circuit Flares as Bipolar Youth Misread Faces

Press Release

Youth with bipolar disorder misread facial expressions as hostile and show heightened neural reactions when they focus on emotional aspects of neutral faces, NIMH researchers have discovered.

Continue Reading…

Lithium Blocks Enzyme To Help Cells’ Clocks Keep On Tickin’

Science Update

NIMH-funded researchers have discovered how lithium likely fixes body clocks gone awry, stabilizing sleep-wake cycles and other daily rhythms disturbed along with mood in bipolar disorder.

Continue Reading…

Largest Study to Date on Pediatric Bipolar Disorder Describes Disease Characteristics And Short-Term Outcomes

Science Update

Recent findings from the multi-site, NIMH-funded Course and Outcome of Bipolar Illness in Youth (COBY) study are helping to shape the understanding of three major subtypes of bipolar disorder that affect children and adolescents and how this diagnosis may affect them as adults.

Continue Reading…

Early Findings from Largest NIMH-Funded Research Program on Bipolar Disorder Begin to Build Evidence-Base on Best Treatment Options

Science Update

Findings from an NIMH research program on bipolar disorder provide much needed long-term data on the chronic, recurrent course of the disorder, and begin the work of building an evidence-base on the best treatments for those with the disorder.

Continue Reading…

Mutant Gene Linked to Treatment-Resistant Depression

Science Update

A mutant gene that starves the brain of serotonin, a mood-regulating chemical messenger, has been discovered and found to be 10 times more prevalent in depressed patients than in control subjects, report researchers funded by the National Institutes of Health’s National Institute of Mental Health (NIMH) and National Heart Lung and Blood Institute (NHLBI).

Continue Reading…

Stress Impairs Thinking Via Mania-Linked Enzyme

Press Release

An errant enzyme linked to bipolar disorder, in the brain’s prefrontal cortex, impairs cognition under stress, an animal study shows.

Continue Reading…

Mental Illness Genetics Among Science’s Top “Breakthroughs“ for 2003

Press Release

Research on the genetics of mental illness, most of it NIMH-funded and much of it in the Institute’s own laboratories, was named the #2 scientific "breakthrough of the year" by Science magazine in its December l9, 2003, issue.

Continue Reading…

NIMH Awards $22.6 Million for Center for Collaborative Research on Mental Disorders

Press Release

The National Institute of Mental Health (NIMH) has funded a five-year, $22.6 million Center for Collaborative Genetic Studies on Mental Disorders at Rutgers, The State University of New Jersey.

Continue Reading…

Lithium Shows Promise Against Alzheimer’s in Mouse Model

Press Release

An enzyme crucial to formation of Alzheimer’s plaques and tangles may hold promise as a target for future medications, suggest studies in mice and cells.

Continue Reading…

NIMH Awards Howard University $6.5 Million

Press Release

Howard University Hospital Department of Psychiatry in the College of Medicine (HUCM) has been awarded $6.5 million from the National Institute of Mental Health (NIMH) for a five-year project to implement and develop research studies pertaining to mood and anxiety disorders.

Continue Reading…